Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-12-20 4:51 pm Purchase | 2021-12-09 | 13G | RELMADA THERAPEUTICS INC P RLMD | BIOTECHNOLOGY VALUE FUND L P | 1,647,400 5.900% | 1,647,400 (New Position) | Filing History |
| 2021-12-16 5:16 pm Purchase | 2021-12-14 | 13G | CIDARA THERAPEUTICS INC CDTX | BIOTECHNOLOGY VALUE FUND L P | 343,056 10.300% | 119,981 (+53.79%) | Filing History |
| 2021-12-02 5:05 pm Purchase | 2021-11-30 | 13D | OLEMA PHARMACEUTICALS INC OLMA | BIOTECHNOLOGY VALUE FUND L P | 7,411,503 18.400% | 750,000 (+11.26%) | Filing History |
| 2021-11-15 4:58 pm Purchase | 2021-11-03 | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | BIOTECHNOLOGY VALUE FUND L P | 3,596,757 9.990% | 3,596,757 (New Position) | Filing History |
| 2021-11-08 5:20 pm Purchase | 2021-10-28 | 13G | CULLINAN THERAPEUTICS INC CGEM | BIOTECHNOLOGY VALUE FUND L P | 2,606,806 6.000% | 2,606,806 (New Position) | Filing History |
| 2021-10-29 4:29 pm Purchase | 2021-10-21 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BIOTECHNOLOGY VALUE FUND L P | 3,003,879 6.500% | 3,003,879 (New Position) | Filing History |
| 2021-09-15 5:17 pm Purchase | 2021-08-16 | 13G | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 2,498,901 7.700% | 2,498,901 (New Position) | Filing History |
| 2021-09-15 5:14 pm Purchase | 2021-09-13 | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 2,945,807 15.700% | 400,554 (+15.74%) | Filing History |
| 2021-09-07 5:26 pm Purchase | 2021-08-26 | 13G | WHITEHAWK THERAPEUTICS, INC. C WHWK | BIOTECHNOLOGY VALUE FUND L P | 1,147,052 5.500% | 1,147,052 (New Position) | Filing History |
| 2021-07-08 5:00 pm Purchase | 2021-07-06 | 13G | CALITHERA BIOSCIENCES INC CALA | BIOTECHNOLOGY VALUE FUND L P | 372,617 10.100% | 154,555 (+70.88%) | Filing History |
| 2021-07-07 4:35 pm Sale | 2021-07-02 | 13G | MERUS N V COM MRUS | BIOTECHNOLOGY VALUE FUND L P | 5,060,071 13.200% | -745,500 (-12.84%) | Filing History |
| 2021-07-06 5:16 pm Purchase | 2021-07-01 | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 2,545,253 13.600% | 599,304 (+30.80%) | Filing History |
| 2021-07-06 5:01 pm Purchase | 2021-06-25 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BIOTECHNOLOGY VALUE FUND L P | 2,005,862 7.500% | 2,005,862 (New Position) | Filing History |